Condition
Allergic Bronchopulmonary Aspergillosis clinical trials and research
As of November 12, 2026, Find a Trial lists 7 Allergic Bronchopulmonary Aspergillosis clinical trials that are recruiting, at sites in 2 countries (most in China (5), India (2)). By phase: Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 7Clinical trials
- 2Countries
Newest Allergic Bronchopulmonary Aspergillosis clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| ML-based ABPA recurrence predictor in adults with ABPA | — | Jinan, Shandong | Recruiting | Jul 20, 2026 |
| Fungal status and prognosis in ABPA: looking at who improves based on fungal tests | — | Jinan, Shandong | Recruiting | Jul 8, 2026 |
| Benralizumab treatment for adults with ABPA and severe asthma | — | Jinan, Shandong and 1 other locations | Recruiting | Apr 15, 2026 |
| Biologic treatment for adults with ABPA and severe asthma | — | Jinan, Shandong | Recruiting | Jan 23, 2026 |
| Bronchoscopic airway clearance with amphotericin B spraying for ABPA | — | Jinan, Shandong | Recruiting | Jan 23, 2026 |
| Comparing Prednisolone and Itraconazole for Allergic Bronchopulmonary Aspergillosis | Phase 3 | Chandigarh, Chandigarh | Recruiting | Dec 18, 2023 |
| Comparing oral itraconazole alone versus with glucocorticoids for lung disease overlap | — | Chandigarh, Chandigarh and 1 other locations | Recruiting | Jul 6, 2022 |
All recruiting trials (7)
-
ML-based ABPA recurrence predictor in adults with ABPA
A machine-learning model is being tested to see if it can predict the chance of an ABPA flare within a year in adults with ABPA during a stable phase.
-
Fungal status and prognosis in ABPA: looking at who improves based on fungal tests
This study checks if ABPA patients with positive or negative fungal tests in sputum or BALF have different outcomes over a year.
-
Benralizumab treatment for adults with ABPA and severe asthma
This will test whether benralizumab helps adults (18–75) who have severe asthma with allergic bronchopulmonary aspergillosis (ABPA).
-
Biologic treatment for adults with ABPA and severe asthma
This project will test whether biologic medicines help adults with ABPA who have severe asthma and elevated eosinophils.
-
Bronchoscopic airway clearance with amphotericin B spraying for ABPA
This study will try bronchoscopic airway clearance plus amphotericin B spraying to see if it helps adults with allergic bronchopulmonary aspergillosis (ABPA) who have mucus plugs.
-
Comparing Prednisolone and Itraconazole for Allergic Bronchopulmonary Aspergillosis
This study is testing whether prednisolone, itraconazole, or a combination of both can help adults with allergic bronchopulmonary aspergillosis feel better and reduce flare-ups over a year.
-
Comparing oral itraconazole alone versus with glucocorticoids for lung disease overlap
This study tests whether taking oral itraconazole alone or with glucocorticoids helps people with both Chronic Pulmonary Aspergillosis and Allergic Bronchopulmonary Aspergillosis feel better.
Related topics
Quick answers
How many Allergic Bronchopulmonary Aspergillosis clinical trials are recruiting right now?
7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in China (5 trials), India (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.